Phase I study of ON 01910.Na (Rigosertib), a multikinase PI3K inhibitor in relapsed/refractory B-cell malignancies

被引：18

作者：

Roschewski, M. ^{[1
,2
]}

Farooqui, M. ^{[2
]}

Aue, G. ^{[2
]}

Wilhelm, F. ^{[3
]}

Wiestner, A. ^{[2
]}

机构：

[1] NCI, Metab Branch, NIH, Bethesda, MD 20892 USA

[2] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA

[3] Onconova Therapeut Inc, Newtown, PA USA

来源：

LEUKEMIA | 2013年 / 27卷 / 09期

关键词：

CHRONIC LYMPHOCYTIC-LEUKEMIA; SMALL-MOLECULE INHIBITOR; SOLID TUMORS; CYCLIN D1; DIAGNOSIS; LYMPHOMA; CRITERIA; CANCER; AGENTS;

D O I：

10.1038/leu.2013.79

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1920 / 1923

页数：5

共 14 条

[1] ON 01910.Na Is Selectively Cytotoxic for Chronic Lymphocytic Leukemia Cells through a Dual Mechanism of Action Involving PI3K/AKT Inhibition and Induction of Oxidative Stress [J].

Chapman, Colby M. ;

Sun, Xiameng ;

Roschewski, Mark ;

Aue, Georg ;

Farooqui, Mohamed ;

Stennett, Lawrence ;

Gibellini, Federica ;

Arthur, Diane ;

Perez-Galan, Patricia ;

Wiestner, Adrian .

CLINICAL CANCER RESEARCH, 2012, 18 (07) :1979-1991

[2] Revised response criteria for malignant lymphoma [J].

Cheson, Bruce D. ;

Pfistner, Beate ;

Juweid, Malik E. ;

Gascoyne, Randy D. ;

Specht, Lena ;

Horning, Sandra J. ;

Coiffier, Bertrand ;

Fisher, Richard I. ;

Hagenbeek, Anton ;

Zucca, Emanuele ;

Rosen, Steven T. ;

Stroobants, Sigrid ;

Lister, T. Andrew ;

Hoppe, Richard T. ;

Dreyling, Martin ;

Tobinai, Kensei ;

Vose, Julie M. ;

Connors, Joseph M. ;

Federico, Massimo ;

Diehl, Volker .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :579-586

[3] ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent [J].

Gumireddy, K ;

Reddy, MVR ;

Cosenza, SC ;

Nathan, RB ;

Baker, SJ ;

Papathi, N ;

Jiang, JD ;

Holland, J ;

Reddy, EP .

CANCER CELL, 2005, 7 (03) :275-286

[4] Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia:: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines [J].

Hallek, Michael ;

Cheson, Bruce D. ;

Catovsky, Daniel ;

Caligaris-Cappio, Federico ;

Dighiero, Guillaume ;

Doehner, Hartmut ;

Hillmen, Peter ;

Keating, Michael J. ;

Montserrat, Emili ;

Rai, Kanti R. ;

Kipps, Thomas J. .

BLOOD, 2008, 111 (12) :5446-5456

[5] Phase I Study of ON 01910.Na, a Novel Modulator of the Polo-Like Kinase 1 Pathway, in Adult Patients With Solid Tumors [J].

Jimeno, Antonio ;

Li, Jing ;

Messersmith, Wells A. ;

Laheru, Daniel ;

Rudek, Michelle A. ;

Maniar, Manoj ;

Hidalgo, Manuel ;

Baker, Sharyn D. ;

Donehower, Ross C. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (34) :5504-5510

[6] Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma [J].

Kyle, R. A. ;

Rajkumar, S. V. .

LEUKEMIA, 2009, 23 (01) :3-9

[7] The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1 [J].

Lenart, Peter ;

Petronczki, Mark ;

Steegmaier, Martin ;

Di Fiore, Barbara ;

Lipp, Jesse J. ;

Hoffmann, Matthias ;

Rettig, Wolfgang J. ;

Kraut, Norbert ;

Peters, Jan-Michael .

CURRENT BIOLOGY, 2007, 17 (04) :304-315

[8] Phase I Study of Rigosertib, an Inhibitor of the Phosphatidylinositol 3-Kinase and Polo-like Kinase 1 Pathways, Combined with Gemcitabine in Patients with Solid Tumors and Pancreatic Cancer [J].

Ma, Wen Wee ;

Messersmith, Wells A. ;

Dy, Grace K. ;

Weekes, Colin D. ;

Whitworth, Amy ;

Ren, Chen ;

Maniar, Manoj ;

Wilhelm, Francois ;

Eckhardt, S. Gail ;

Adjei, Alex A. ;

Jimeno, Antonio .

CLINICAL CANCER RESEARCH, 2012, 18 (07) :2048-2055

[9] Directed therapy for patients with myelodysplastic syndromes (MDS) by suppression of cyclin D1 with ON 01910.Na [J].

Olnes, Matthew J. ;

Shenoy, Aarthie ;

Weinstein, Barbara ;

Pfannes, Loretta ;

Loeliger, Kelsey ;

Tucker, Zachary ;

Tian, Xin ;

Kwak, Minjung ;

Wilhelm, Francois ;

Yong, Agnes S. M. ;

Maric, Irina ;

Maniar, Manoj ;

Scheinberg, Phillip ;

Groopman, Jerome ;

Young, Neal S. ;

Sloand, Elaine M. .

LEUKEMIA RESEARCH, 2012, 36 (08) :982-989

[10] Effect of ON 01910.Na, an Anticancer Mitotic Inhibitor, on Cell-Cycle Progression Correlates with RanGAP1 Hyperphosphorylation [J].

Oussenko, Irina A. ;

Holland, James F. ;

Reddy, E. Premkumar ;

Ohnuma, Takao .

CANCER RESEARCH, 2011, 71 (14) :4968-4976

← 1 2 →